Carregant...
ACEi reduces hypertension-induced hyperinflammation in COVID-19
Antihypertensive therapy, particularly with the use of an angiotensin-converting enzyme inhibitor, improves outcomes in patients with hypertension and SARS-CoV-2 infection, who are susceptible to hyperinflammation and severe outcomes with COVID-19.
Guardat en:
| Publicat a: | Nat Rev Cardiol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812557/ https://ncbi.nlm.nih.gov/pubmed/33462417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41569-021-00512-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|